Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology

Katherine J. Bangen, Jayandra J. Himali, Alexa S. Beiser, Daniel A. Nation, David J. Libon, Caroline S. Fox, Sudha Seshadri, Philip A. Wolf, Ann C. McKee, Rhoda Au, Lisa Delano-Wood

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Elevated blood glucose and the apolipoprotein (APOE) ϵ4 allele have both been associated with increased dementia risk; however, the neuropathological mechanisms underlying these associations remain unclear. We examined the impact of APOE genotype and midlife blood glucose on post-mortem vascular and Alzheimer's disease (AD) neuropathology. Ninety-four participants from the Framingham Heart Study without diagnosed diabetes underwent health examination at midlife and brain autopsy at death. Histopathological measures of vascular and AD neuropathology were obtained and analyzed. Results demonstrated that, among APOE ϵ4 carriers, elevated blood glucose was associated with more severe AD pathology. There was no such relationship with vascular pathology. In a relatively healthy sample with low vascular risk burden, midlife elevated blood glucose was associated with greater AD pathology among APOE ϵ4 carriers. A better understanding of interactive effects of APOE genotype and vascular risk on neuropathology has implications for identification of individuals at risk for decline and long-term preventive treatment.

Original languageEnglish (US)
Pages (from-to)1553-1562
Number of pages10
JournalJournal of Alzheimer's Disease
Volume53
Issue number4
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Apolipoproteins
Blood Glucose
Alzheimer Disease
Genotype
Pathology
Blood Vessels
Vascular Diseases
Dementia
Autopsy
Alleles
Health
Brain
Neuropathology

Keywords

  • Alzheimer's disease
  • Apolipoprotein E (APOE)
  • Diabetes
  • Glucose
  • Neuropathology
  • Vascular risk

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Bangen, K. J., Himali, J. J., Beiser, A. S., Nation, D. A., Libon, D. J., Fox, C. S., ... Delano-Wood, L. (2016). Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology. Journal of Alzheimer's Disease, 53(4), 1553-1562. https://doi.org/10.3233/JAD-160163

Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology. / Bangen, Katherine J.; Himali, Jayandra J.; Beiser, Alexa S.; Nation, Daniel A.; Libon, David J.; Fox, Caroline S.; Seshadri, Sudha; Wolf, Philip A.; McKee, Ann C.; Au, Rhoda; Delano-Wood, Lisa.

In: Journal of Alzheimer's Disease, Vol. 53, No. 4, 01.01.2016, p. 1553-1562.

Research output: Contribution to journalArticle

Bangen, KJ, Himali, JJ, Beiser, AS, Nation, DA, Libon, DJ, Fox, CS, Seshadri, S, Wolf, PA, McKee, AC, Au, R & Delano-Wood, L 2016, 'Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology', Journal of Alzheimer's Disease, vol. 53, no. 4, pp. 1553-1562. https://doi.org/10.3233/JAD-160163
Bangen, Katherine J. ; Himali, Jayandra J. ; Beiser, Alexa S. ; Nation, Daniel A. ; Libon, David J. ; Fox, Caroline S. ; Seshadri, Sudha ; Wolf, Philip A. ; McKee, Ann C. ; Au, Rhoda ; Delano-Wood, Lisa. / Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology. In: Journal of Alzheimer's Disease. 2016 ; Vol. 53, No. 4. pp. 1553-1562.
@article{109cb24d85774420ab4a10e275053e7d,
title = "Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology",
abstract = "Elevated blood glucose and the apolipoprotein (APOE) ϵ4 allele have both been associated with increased dementia risk; however, the neuropathological mechanisms underlying these associations remain unclear. We examined the impact of APOE genotype and midlife blood glucose on post-mortem vascular and Alzheimer's disease (AD) neuropathology. Ninety-four participants from the Framingham Heart Study without diagnosed diabetes underwent health examination at midlife and brain autopsy at death. Histopathological measures of vascular and AD neuropathology were obtained and analyzed. Results demonstrated that, among APOE ϵ4 carriers, elevated blood glucose was associated with more severe AD pathology. There was no such relationship with vascular pathology. In a relatively healthy sample with low vascular risk burden, midlife elevated blood glucose was associated with greater AD pathology among APOE ϵ4 carriers. A better understanding of interactive effects of APOE genotype and vascular risk on neuropathology has implications for identification of individuals at risk for decline and long-term preventive treatment.",
keywords = "Alzheimer's disease, Apolipoprotein E (APOE), Diabetes, Glucose, Neuropathology, Vascular risk",
author = "Bangen, {Katherine J.} and Himali, {Jayandra J.} and Beiser, {Alexa S.} and Nation, {Daniel A.} and Libon, {David J.} and Fox, {Caroline S.} and Sudha Seshadri and Wolf, {Philip A.} and McKee, {Ann C.} and Rhoda Au and Lisa Delano-Wood",
year = "2016",
month = "1",
day = "1",
doi = "10.3233/JAD-160163",
language = "English (US)",
volume = "53",
pages = "1553--1562",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Interaction between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology

AU - Bangen, Katherine J.

AU - Himali, Jayandra J.

AU - Beiser, Alexa S.

AU - Nation, Daniel A.

AU - Libon, David J.

AU - Fox, Caroline S.

AU - Seshadri, Sudha

AU - Wolf, Philip A.

AU - McKee, Ann C.

AU - Au, Rhoda

AU - Delano-Wood, Lisa

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Elevated blood glucose and the apolipoprotein (APOE) ϵ4 allele have both been associated with increased dementia risk; however, the neuropathological mechanisms underlying these associations remain unclear. We examined the impact of APOE genotype and midlife blood glucose on post-mortem vascular and Alzheimer's disease (AD) neuropathology. Ninety-four participants from the Framingham Heart Study without diagnosed diabetes underwent health examination at midlife and brain autopsy at death. Histopathological measures of vascular and AD neuropathology were obtained and analyzed. Results demonstrated that, among APOE ϵ4 carriers, elevated blood glucose was associated with more severe AD pathology. There was no such relationship with vascular pathology. In a relatively healthy sample with low vascular risk burden, midlife elevated blood glucose was associated with greater AD pathology among APOE ϵ4 carriers. A better understanding of interactive effects of APOE genotype and vascular risk on neuropathology has implications for identification of individuals at risk for decline and long-term preventive treatment.

AB - Elevated blood glucose and the apolipoprotein (APOE) ϵ4 allele have both been associated with increased dementia risk; however, the neuropathological mechanisms underlying these associations remain unclear. We examined the impact of APOE genotype and midlife blood glucose on post-mortem vascular and Alzheimer's disease (AD) neuropathology. Ninety-four participants from the Framingham Heart Study without diagnosed diabetes underwent health examination at midlife and brain autopsy at death. Histopathological measures of vascular and AD neuropathology were obtained and analyzed. Results demonstrated that, among APOE ϵ4 carriers, elevated blood glucose was associated with more severe AD pathology. There was no such relationship with vascular pathology. In a relatively healthy sample with low vascular risk burden, midlife elevated blood glucose was associated with greater AD pathology among APOE ϵ4 carriers. A better understanding of interactive effects of APOE genotype and vascular risk on neuropathology has implications for identification of individuals at risk for decline and long-term preventive treatment.

KW - Alzheimer's disease

KW - Apolipoprotein E (APOE)

KW - Diabetes

KW - Glucose

KW - Neuropathology

KW - Vascular risk

UR - http://www.scopus.com/inward/record.url?scp=84981743144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981743144&partnerID=8YFLogxK

U2 - 10.3233/JAD-160163

DO - 10.3233/JAD-160163

M3 - Article

VL - 53

SP - 1553

EP - 1562

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -